95 related articles for article (PubMed ID: 27620667)
41. In Silico Analysis of FMR1 Gene Missense SNPs.
Tekcan A
Cell Biochem Biophys; 2016 Jun; 74(2):109-27. PubMed ID: 26880065
[TBL] [Abstract][Full Text] [Related]
42. Increased plasma guanylin levels in patients with impaired renal function.
Kinoshita H; Nakazato M; Yamaguchi H; Matsukura S; Fujimoto S; Eto T
Clin Nephrol; 1997 Jan; 47(1):28-32. PubMed ID: 9021238
[TBL] [Abstract][Full Text] [Related]
43. Computational analysis of sodium-dependent phosphate transporter SLC20A1/PiT1 gene identifies missense variations C573F, and T58A as high-risk deleterious SNPs.
Siva Sankari G; James R; Payva F; Sivaramakrishnan V; Vineeth Kumar TV; Kanchi S; Santhy KS
J Biomol Struct Dyn; 2024 May; 42(8):4072-4086. PubMed ID: 37286379
[TBL] [Abstract][Full Text] [Related]
44. Molecular dynamics investigation of cyclic natriuretic peptides: dynamic properties reflect peptide activity.
Papaleo E; Russo L; Shaikh N; Cipolla L; Fantucci P; De Gioia L
J Mol Graph Model; 2010 Jun; 28(8):834-41. PubMed ID: 20347361
[TBL] [Abstract][Full Text] [Related]
45. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
[TBL] [Abstract][Full Text] [Related]
46. Functional analysis of the human guanylin gene promoter.
Pardigol A; Mägert HJ; Hill O; Forssmann WG
Biochem Biophys Res Commun; 1996 Jul; 224(3):638-44. PubMed ID: 8713101
[TBL] [Abstract][Full Text] [Related]
47. In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.
Liu D; Overbey D; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA; Giblin MF
Anticancer Res; 2009 Oct; 29(10):3777-83. PubMed ID: 19846908
[TBL] [Abstract][Full Text] [Related]
48. Characterization of NPHS2 gene polymorphisms associated to steroid resistance nephrotic syndrome in Indian children.
Joshi BB; Mistry KN; Gang S; Koringa PG; Joshi CG
Gene; 2017 Sep; 628():134-140. PubMed ID: 28712774
[TBL] [Abstract][Full Text] [Related]
49. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load.
Lorenz JN; Nieman M; Sabo J; Sanford LP; Hawkins JA; Elitsur N; Gawenis LR; Clarke LL; Cohen MB
J Clin Invest; 2003 Oct; 112(8):1244-54. PubMed ID: 14561709
[TBL] [Abstract][Full Text] [Related]
50. Expression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine.
Qian X; Prabhakar S; Nandi A; Visweswariah SS; Goy MF
Endocrinology; 2000 Sep; 141(9):3210-24. PubMed ID: 10965892
[TBL] [Abstract][Full Text] [Related]
51. Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity.
Kim GW; Lin JE; Snook AE; Aing AS; Merlino DJ; Li P; Waldman SA
Nutr Diabetes; 2016 May; 6(5):e211. PubMed ID: 27214655
[TBL] [Abstract][Full Text] [Related]
52. Unraveling the function and structure impact of deleterious missense SNPs in the human OX1R receptor by computational analysis.
Farajzadeh-Dehkordi M; Mafakher L; Harifi A; Haghdoost-Yazdi H; Piri H; Rahmani B
Sci Rep; 2024 Jan; 14(1):833. PubMed ID: 38191899
[TBL] [Abstract][Full Text] [Related]
53. Genomic structure and chromosomal localization of human uroguanylin.
Miyazato M; Nakazato M; Matsukura S; Kangawa K; Matsuo H
Genomics; 1997 Aug; 43(3):359-65. PubMed ID: 9268639
[TBL] [Abstract][Full Text] [Related]
54. Expression of guanylate cyclase-C, guanylin, and uroguanylin is downregulated proportionally to the ulcerative colitis disease activity index.
Lan D; Niu J; Miao J; Dong X; Wang H; Yang G; Wang K; Miao Y
Sci Rep; 2016 Apr; 6():25034. PubMed ID: 27125248
[TBL] [Abstract][Full Text] [Related]
55. Identification of two functional guanylin receptors in eel: multiple hormone-receptor system for osmoregulation in fish intestine and kidney.
Yuge S; Yamagami S; Inoue K; Suzuki N; Takei Y
Gen Comp Endocrinol; 2006 Oct; 149(1):10-20. PubMed ID: 16753163
[TBL] [Abstract][Full Text] [Related]
56. Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK missense mutations in structural perspective.
Doss CG; Chakraborty C; Chen L; Zhu H
Biomed Res Int; 2014; 2014():895831. PubMed ID: 25054154
[TBL] [Abstract][Full Text] [Related]
57. In-Silico analysis of missense SNPs in Human HPPD gene associated with Tyrosinemia type III and Hawkinsinuria.
Naveed M; Tehreem S; Mehboob MZ
Comput Biol Chem; 2019 Jun; 80():284-291. PubMed ID: 31054541
[TBL] [Abstract][Full Text] [Related]
58. Impact of deleterious missense PRKCI variants on structural and functional dynamics of protein.
Shah H; Khan K; Khan N; Badshah Y; Ashraf NM; Shabbir M
Sci Rep; 2022 Mar; 12(1):3781. PubMed ID: 35260606
[TBL] [Abstract][Full Text] [Related]
59. Uroguanylin: a new actor in the energy balance movie.
Folgueira C; Barja-Fernandez S; Gonzalez-Saenz P; Pena-Leon V; Castelao C; Ruiz-Piñon M; Casanueva FF; Nogueiras R; Seoane LM
J Mol Endocrinol; 2018 Feb; 60(2):R31-R38. PubMed ID: 29203517
[TBL] [Abstract][Full Text] [Related]
60. Computational analysis of the functional and structural impact of the most deleterious missense mutations in the human Protein C.
Farajzadeh-Dehkordi M; Mafakher L; Harifi A; Samiee-Rad F; Rahmani B
PLoS One; 2023; 18(11):e0294417. PubMed ID: 38015884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
